Malignant gliomas represent a difficult and challenging problem for oncologists. While roles for some chemokines in the biology of tumors are fast emerging, no published information is available on the involvement of the specific chemokine, fractalkine (FKN), and its receptor, CX3CR1, in intracranial tumors. We have identified FKN and CX3CR1 expression in the syngeneic murine GL261 glioma model. Since microglia represent the major CX3CR1-expressing cell in the CNS, these cytotoxic effector cells most likely underlie any role for FKN and CX3CR1 in the biology of intracranial tumors. The lack of highly selective CX3CR1 antagonists has hampered further understanding of FKN and CX3CR1 in these and other diseases. Our approach to this dilemma has centered on the development and characterization of modified virally encoded chemokine receptor antagonists based upon the CC chemokine encoded by human herpes virus 8, vMIP-ll. We have made a simple modification to the vMIP-ll sequence, inserting three amino acids (Asn-lle-Thr) between the first two conserved cysteine residues. The resultant peptide, vMIP-ll/NIT, displays enhanced affinity and selectivity for CX3CR1. We will take advantage of the similarities and differences between the CX3CR1 selective agonist, FKN, and the non-selective chemokine receptor antagonist, vMIP-ll, by generating and characterizing site-specific and chimeric FKN/vMIP-ll mutants. The results will shed insights into the properties of FKN that mediate affinity, selectivity, and signaling efficacy at CX3CR1. From this, high affinity selective CX3CR1 antagonists will be developed and their properties tested in in vivo models of intracranial tumor growth and host rejection.
The aims are designed to: Evaluate intracranial GL261 tumor growth, necrotic index, and immune response after implantation of GL261 cells into mice deficient in CX3CR1. Determine structural features of FKN important for affinity, selectivity, and agonist activity at CX3CR1. Determine the antagonist properties of vMIP-ll/FKN chimeras and mutants in vivo using the intracranial GL261 glioma model. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI058256-03
Application #
7432484
Study Section
Transplantation, Tolerance, and Tumor Immunology (TTT)
Program Officer
Miller, Lara R
Project Start
2006-06-01
Project End
2011-05-31
Budget Start
2008-06-01
Budget End
2009-05-31
Support Year
3
Fiscal Year
2008
Total Cost
$383,587
Indirect Cost
Name
University of Florida
Department
Pharmacology
Type
Schools of Medicine
DUNS #
969663814
City
Gainesville
State
FL
Country
United States
Zip Code
32611
Liu, Che; Pham, Kien; Luo, Defang et al. (2013) Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells. PLoS One 8:e59750
Rajasekaran, Deepa; Keeler, Camille; Syed, Mansoor A et al. (2012) A model of GAG/MIP-2/CXCR2 interfaces and its functional effects. Biochemistry 51:5642-54
Denoyer, Alexandre; Godefroy, David; Celerier, Isabelle et al. (2012) CXCR3 antagonism of SDF-1(5-67) restores trabecular function and prevents retinal neurodegeneration in a rat model of ocular hypertension. PLoS One 7:e37873
Pham, Kien; Luo, Defang; Liu, Che et al. (2012) CCL5, CCR1 and CCR5 in murine glioblastoma: immune cell infiltration and survival rates are not dependent on individual expression of either CCR1 or CCR5. J Neuroimmunol 246:10-7
Zhang, Jianliang; Hu, Hanbo; Palma, Nadia L et al. (2012) Hypoxia-induced endothelial CX3CL1 triggers lung smooth muscle cell phenotypic switching and proliferative expansion. Am J Physiol Lung Cell Mol Physiol 303:L912-22
Liu, Che; Luo, Defang; Reynolds, Brent A et al. (2011) Chemokine receptor CXCR3 promotes growth of glioma. Carcinogenesis 32:129-37
Bachstetter, Adam D; Morganti, Josh M; Jernberg, Jennifer et al. (2011) Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol Aging 32:2030-44
Laughlin, Katharine M; Luo, Defang; Liu, Che et al. (2009) Hematopoietic- and neurologic-expressed sequence 1 expression in the murine GL261 and high-grade human gliomas. Pathol Oncol Res 15:437-44
Laughlin, Katharine M; Luo, Defang; Liu, Che et al. (2009) Hematopoietic- and neurologic-expressed sequence 1 (Hn1) depletion in B16.F10 melanoma cells promotes a differentiated phenotype that includes increased melanogenesis and cell cycle arrest. Differentiation 78:35-44
Liu, Che; Luo, Defang; Streit, Wolfgang J et al. (2008) CX3CL1 and CX3CR1 in the GL261 murine model of glioma: CX3CR1 deficiency does not impact tumor growth or infiltration of microglia and lymphocytes. J Neuroimmunol 198:98-105